Avanos Cost Of Revenue vs Gross Profit Analysis

AVNS Stock

USD 20.09 0.21 1.06%

Avanos Medical financial indicator trend analysis is way more than just evaluating Avanos Medical prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Avanos Medical is a good investment. Please check the relationship between Avanos Medical Cost Of Revenue and its Gross Profit accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avanos Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.

Cost Of Revenue vs Gross Profit

Cost Of Revenue vs Gross Profit Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Avanos Medical Cost Of Revenue account and Gross Profit. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Avanos Medical's Cost Of Revenue and Gross Profit is 0.95. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Gross Profit in the same time period over historical financial statements of Avanos Medical, assuming nothing else is changed. The correlation between historical values of Avanos Medical's Cost Of Revenue and Gross Profit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Avanos Medical are associated (or correlated) with its Gross Profit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Gross Profit has no effect on the direction of Cost Of Revenue i.e., Avanos Medical's Cost Of Revenue and Gross Profit go up and down completely randomly.

Correlation Coefficient

0.95

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Avanos Medical income statement and represents the costs associated with goods and services Avanos Medical provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Avanos Medical minus its cost of goods sold. It is profit before Avanos Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most indicators from Avanos Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Avanos Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avanos Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.At this time, Avanos Medical's Discontinued Operations is comparatively stable compared to the past year. Tax Provision is likely to gain to about 2.1 M in 2024, whereas Selling General Administrative is likely to drop slightly above 286.2 M in 2024.

	2021	2022	2024 (projected)
Interest Expense	3.3M	10M	16.1M
Depreciation And Amortization	38.5M	48.9M	43.6M

Interest Expense Depreciation And Amortization

Avanos Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Good Will	Common Stock Total Equity	Retained Earnings Total Equity	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Treasury Stock	Short Term Debt	Intangible Assets
Total Assets		0.81	0.93	0.91	0.42	0.0	-0.19	0.78	0.39	0.16	0.84	0.94	0.95	0.89	-0.22	-0.06	0.84	0.31	0.92	0.75	0.2	0.19	0.81	0.01	0.22	0.63
Other Current Liab	0.81		0.72	0.76	0.39	-0.28	-0.12	0.55	0.1	0.26	0.7	0.76	0.87	0.74	-0.11	-0.13	0.92	0.45	0.76	0.55	0.27	0.34	0.41	0.04	0.38	0.55
Total Current Liabilities	0.93	0.72		0.76	0.53	-0.11	-0.19	0.89	0.41	0.22	0.91	0.9	0.85	0.77	-0.21	-0.16	0.76	0.28	0.78	0.86	0.27	0.32	0.88	0.21	0.35	0.48
Total Stockholder Equity	0.91	0.76	0.76		0.2	0.06	-0.06	0.53	0.27	-0.02	0.68	0.82	0.92	0.84	-0.05	0.13	0.77	0.53	0.96	0.44	0.01	-0.08	0.64	-0.13	-0.03	0.68
Other Liab	0.42	0.39	0.53	0.2		0.1	-0.69	0.51	0.27	0.5	0.36	0.51	0.26	0.56	-0.67	0.01	0.38	0.2	0.38	0.67	0.93	0.6	0.55	-0.29	0.61	0.56
Net Tangible Assets	0.0	-0.28	-0.11	0.06	0.1		-0.55	-0.08	0.61	-0.31	-0.45	0.03	-0.2	0.35	-0.52	0.37	-0.38	0.18	0.21	-0.07	0.11	-0.4	0.28	-0.68	-0.42	0.46
Retained Earnings	-0.19	-0.12	-0.19	-0.06	-0.69	-0.55		-0.29	-0.46	-0.37	0.04	-0.37	0.02	-0.53	0.98	-0.41	-0.11	-0.15	-0.33	-0.42	-0.76	-0.5	-0.41	0.53	-0.48	-0.47
Accounts Payable	0.78	0.55	0.89	0.53	0.51	-0.08	-0.29		0.62	0.34	0.82	0.81	0.67	0.64	-0.35	-0.11	0.62	0.1	0.6	0.9	0.28	0.49	0.85	0.3	0.49	0.29
Cash	0.39	0.1	0.41	0.27	0.27	0.61	-0.46	0.62		0.0	0.13	0.42	0.18	0.51	-0.49	0.2	0.02	0.18	0.38	0.47	0.12	0.0	0.64	-0.16	-0.01	0.41
Other Assets	0.16	0.26	0.22	-0.02	0.5	-0.31	-0.37	0.34	0.0		0.26	0.19	0.15	0.17	-0.4	-0.01	0.29	-0.14	0.1	0.4	0.57	0.67	0.08	0.11	0.66	0.17
Long Term Debt	0.84	0.7	0.91	0.68	0.36	-0.45	0.04	0.82	0.13	0.26		0.81	0.84	0.55	-0.01	-0.24	0.83	0.1	0.64	0.78	0.13	0.43	0.69	0.45	0.46	0.21
Net Receivables	0.94	0.76	0.9	0.82	0.51	0.03	-0.37	0.81	0.42	0.19	0.81		0.87	0.89	-0.39	0.11	0.83	0.3	0.88	0.84	0.32	0.31	0.84	-0.05	0.33	0.59
Good Will	0.95	0.87	0.85	0.92	0.26	-0.2	0.02	0.67	0.18	0.15	0.84	0.87		0.78	-0.01	-0.08	0.92	0.33	0.87	0.62	0.05	0.15	0.62	0.09	0.19	0.53
Common Stock Total Equity	0.89	0.74	0.77	0.84	0.56	0.35	-0.53	0.64	0.51	0.17	0.55	0.89	0.78		-0.52	0.21	0.7	0.48	0.95	0.65	0.42	0.16	0.77	-0.39	0.18	0.83
Retained Earnings Total Equity	-0.22	-0.11	-0.21	-0.05	-0.67	-0.52	0.98	-0.35	-0.49	-0.4	-0.01	-0.39	-0.01	-0.52		-0.31	-0.14	0.01	-0.33	-0.46	-0.72	-0.55	-0.43	0.44	-0.53	-0.43
Common Stock Shares Outstanding	-0.06	-0.13	-0.16	0.13	0.01	0.37	-0.41	-0.11	0.2	-0.01	-0.24	0.11	-0.08	0.21	-0.31		-0.11	0.45	0.2	-0.1	0.1	-0.16	0.09	-0.59	-0.16	0.23
Inventory	0.84	0.92	0.76	0.77	0.38	-0.38	-0.11	0.62	0.02	0.29	0.83	0.83	0.92	0.7	-0.14	-0.11		0.24	0.77	0.63	0.24	0.45	0.46	0.13	0.49	0.42
Other Current Assets	0.31	0.45	0.28	0.53	0.2	0.18	-0.15	0.1	0.18	-0.14	0.1	0.3	0.33	0.48	0.01	0.45	0.24		0.51	-0.01	0.14	-0.2	0.26	-0.36	-0.17	0.53
Other Stockholder Equity	0.92	0.76	0.78	0.96	0.38	0.21	-0.33	0.6	0.38	0.1	0.64	0.88	0.87	0.95	-0.33	0.2	0.77	0.51		0.54	0.23	0.08	0.72	-0.26	0.11	0.78
Total Liab	0.75	0.55	0.86	0.44	0.67	-0.07	-0.42	0.9	0.47	0.4	0.78	0.84	0.62	0.65	-0.46	-0.1	0.63	-0.01	0.54		0.47	0.55	0.82	0.16	0.55	0.33
Deferred Long Term Liab	0.2	0.27	0.27	0.01	0.93	0.11	-0.76	0.28	0.12	0.57	0.13	0.32	0.05	0.42	-0.72	0.1	0.24	0.14	0.23	0.47		0.62	0.31	-0.41	0.62	0.5
Short Long Term Debt	0.19	0.34	0.32	-0.08	0.6	-0.4	-0.5	0.49	0.0	0.67	0.43	0.31	0.15	0.16	-0.55	-0.16	0.45	-0.2	0.08	0.55	0.62		0.18	0.28	1.0	-0.08
Total Current Assets	0.81	0.41	0.88	0.64	0.55	0.28	-0.41	0.85	0.64	0.08	0.69	0.84	0.62	0.77	-0.43	0.09	0.46	0.26	0.72	0.82	0.31	0.18		-0.02	0.19	0.52
Treasury Stock	0.01	0.04	0.21	-0.13	-0.29	-0.68	0.53	0.3	-0.16	0.11	0.45	-0.05	0.09	-0.39	0.44	-0.59	0.13	-0.36	-0.26	0.16	-0.41	0.28	-0.02		0.29	-0.62
Short Term Debt	0.22	0.38	0.35	-0.03	0.61	-0.42	-0.48	0.49	-0.01	0.66	0.46	0.33	0.19	0.18	-0.53	-0.16	0.49	-0.17	0.11	0.55	0.62	1.0	0.19	0.29		-0.05
Intangible Assets	0.63	0.55	0.48	0.68	0.56	0.46	-0.47	0.29	0.41	0.17	0.21	0.59	0.53	0.83	-0.43	0.23	0.42	0.53	0.78	0.33	0.5	-0.08	0.52	-0.62	-0.05

Click cells to compare fundamentals

Avanos Medical Account Relationship Matchups

Avanos Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.8B	1.7B	1.6B	1.8B	1.7B	1.5B
Other Current Liab	114.8M	83.2M	68.1M	98.9M	156.9M	88.7M
Total Current Liabilities	212.5M	166.3M	139.2M	185.8M	234.6M	200.5M
Total Stockholder Equity	1.3B	1.3B	1.3B	1.3B	1.2B	1.4B
Other Liab	11.2M	16.7M	18.7M	48.9M	56.2M	30.6M
Net Tangible Assets	280M	296.3M	321.1M	220.8M	253.9M	181.9M
Retained Earnings	(288.3M)	(315.5M)	(310.3M)	(253.1M)	(314.9M)	(330.6M)
Accounts Payable	83M	67.6M	56.4M	67.9M	56.3M	86.0M
Cash	205.3M	111.5M	118.5M	127.7M	87.7M	147.2M
Other Assets	27.4M	71M	26.5M	22.2M	25.5M	24.3M
Long Term Debt	248.1M	180M	130M	226.3M	159.4M	256.1M
Net Receivables	150.5M	163.8M	167.9M	131.2M	142.8M	183.0M
Good Will	800.9M	802.5M	801.6M	819.4M	796.1M	728.2M
Retained Earnings Total Equity	(288.3M)	(315.5M)	(310.3M)	(253.1M)	(227.8M)	(239.2M)
Common Stock Shares Outstanding	47.6M	47.8M	48.6M	47.3M	46.6M	51.7M
Inventory	145.9M	168.9M	150.3M	190.3M	163.2M	152.4M
Other Current Assets	57.2M	23.5M	18.9M	13.9M	93.3M	98.0M
Other Stockholder Equity	1.6B	1.6B	1.6B	1.6B	1.6B	1.7B
Total Liab	534.4M	416.3M	330.7M	495.7M	456.1M	466.7M
Total Current Assets	538.5M	467.2M	418.6M	499.8M	487M	627.7M
Accumulated Other Comprehensive Income	(32M)	(28.1M)	(33.8M)	(35.8M)	(27M)	(28.4M)
Treasury Stock	(5.3M)	(8.9M)	(9.8M)	(21.3M)	(19.2M)	(18.2M)
Intangible Assets	168.2M	184.3M	157.7M	251M	239.5M	166.7M
Property Plant Equipment	184.5M	175.3M	168.1M	163.9M	147.5M	161.6M
Short Long Term Debt Total	325.4M	248.8M	187.5M	280M	209.1M	264.0M
Property Plant And Equipment Net	248.5M	223.6M	206.7M	194.5M	144M	183.3M
Net Debt	120.1M	137.3M	69M	152.3M	121.4M	148.1M
Non Current Assets Total	1.3B	1.2B	1.2B	1.3B	1.2B	1.1B
Non Currrent Assets Other	11.3M	11.8M	16.5M	17.6M	19.3M	12.0M
Cash And Short Term Investments	205.3M	111.5M	118.5M	127.7M	87.7M	159.4M
Liabilities And Stockholders Equity	1.8B	1.7B	1.6B	1.8B	1.7B	1.6B
Non Current Liabilities Total	321.9M	250M	191.5M	309.9M	221.5M	288.4M
Property Plant And Equipment Gross	248.5M	223.6M	206.7M	194.5M	266.9M	191.5M
Long Term Debt Total	248.1M	180M	130M	226.3M	203.7M	273.0M
Capital Surpluse	1.6B	1.6B	1.6B	1.6B	1.9B	1.7B
Non Current Liabilities Other	73.8M	64.3M	51.9M	18.7M	4.1M	3.9M

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Avanos Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Avanos Medical's short interest history, or implied volatility extrapolated from Avanos Medical options trading.

Pair Trading with Avanos Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Avanos Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avanos Medical will appreciate offsetting losses from the drop in the long position's value.

The ability to find closely correlated positions to Avanos Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Avanos Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Avanos Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Avanos Medical to buy it.

The correlation of Avanos Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Avanos Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Avanos Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Avanos Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Avanos Medical is a strong investment it is important to analyze Avanos Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avanos Medical's future performance. For an informed investment choice regarding Avanos Stock, refer to the following important reports:

How To Invest In Avanos

Details

Is Avanos Stock a good investment?

Details

What is Avanos Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avanos Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.

You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for Avanos Stock analysis

When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.

	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance

Is Avanos Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avanos Medical. If investors know Avanos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avanos Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.38)

Earnings Share

(0.03)

Revenue Per Share

14.626

Quarterly Revenue Growth

0.043

Return On Assets

0.0218

The market value of Avanos Medical is measured differently than its book value, which is the value of Avanos that is recorded on the company's balance sheet. Investors also form their own opinion of Avanos Medical's value that differs from its market value or its book value, called intrinsic value, which is Avanos Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avanos Medical's market value can be influenced by many factors that don't directly affect Avanos Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Avanos Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avanos Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avanos Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Avanos Cost Of Revenue vs Gross Profit Analysis

Cost Of Revenue vs Gross Profit

Cost Of Revenue vs Gross Profit Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Gross Profit

Avanos Medical fundamental ratios Correlations

Avanos Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Avanos Medical fundamental ratios Accounts

Pair Trading with Avanos Medical

Complementary Tools for Avanos Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Short Term Debt	+ 1.0	Short Long Term Debt
Retained Earnings Total Equity	+ 0.98	Retained Earnings
Other Stockholder Equity	+ 0.96	Total Stockholder Equity
Good Will	+ 0.95	Total Assets
Other Stockholder Equity	+ 0.95	Common Stock Total Equity
Net Receivables	+ 0.94	Total Assets

Deferred Long Term Liab	- 0.76	Retained Earnings
Deferred Long Term Liab	- 0.72	Retained Earnings Total Equity
Retained Earnings	- 0.69	Other Liab
Treasury Stock	- 0.68	Net Tangible Assets
Retained Earnings Total Equity	- 0.67	Other Liab
Intangible Assets	- 0.62	Treasury Stock